Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis says Afinitor reduces tumors in rare genetic disease
Reuters
Friday, January 11, 2013 - 11:57am
tags:
Afinitor, Novartis, TSC
Glaxo Future Hangs in Balance on 2013 U.S. Drug Approvals
Bloomberg
Friday, January 11, 2013 - 11:56am
tags:
GSK, drug approvals, albiglutide, relvar, Dolutegravir
J&J Failed to Warn of Vaginal Mesh Risks, Lawyer Says
Bloomberg
Friday, January 11, 2013 - 11:40am
tags:
JNJ, vaginal mesh
JPMorgan Healthcare Conference Highlights: Questcor Pharmaceuticals
Motley Fool
Friday, January 11, 2013 - 11:39am
tags:
JPMHC 2013, Questcor Pharmaceuticals
FDA Panel Backs Novel Diabetes Pill From J&J
Motley Fool
Friday, January 11, 2013 - 11:38am
tags:
FDA, advisory panels, JNJ, diabetes, canagliflozin
Merck steers doctors away from HDL cholesterol drug Tredaptive
Yahoo/Reuters
Friday, January 11, 2013 - 11:37am
tags:
Merck, Tredaptive
JPMorgan Healthcare Conference Highlights: MannKind
Motley Fool
Friday, January 11, 2013 - 11:36am
tags:
JPMHC 2013, MannKind
Sleeping Pill Doses Are Cut for Women
Bloomberg
Friday, January 11, 2013 - 11:36am
tags:
insomnia, women, Ambien, Sanofi
FDA Decision On MAP's Levadex Approaching, Stock Starting To Reflect Optimism
Seeking Alpha
Thursday, January 10, 2013 - 11:45am
tags:
Levadex, FDA, MAP Pharmaceuticals, migraines
Forbes Earnings Preview: Forest Laboratories
Forbes
Thursday, January 10, 2013 - 11:43am
tags:
earnings, Forest Labs
Optimer's Dificid Sales Look Good
Yahoo/Zacks
Thursday, January 10, 2013 - 11:42am
tags:
Optimer, Dificid, earnings
4 Biotech Stocks With Insider Interest
Motley Fool
Thursday, January 10, 2013 - 11:30am
tags:
Infinity Pharmaceuticals, Merrimack Pharmaceuticals, Sarepta, Arena Pharmaceuticals
What's on the Way for Antares Pharma
Motley Fool
Thursday, January 10, 2013 - 11:28am
tags:
Antares, Teva, self-injectibles
JPMorgan Healthcare Conference Highlights: Sarepta Therapeutics
Motley Fool
Thursday, January 10, 2013 - 11:27am
tags:
JPMHC 2013, Sarepta
Pfizer May Push $5 Billion Breast Cancer Hope for Ruling
Bloomberg
Thursday, January 10, 2013 - 11:26am
tags:
Pfizer, breast cancer, PD-0332991
Drugmakers report U.S. shortages of flu vaccine, Tamiflu
Reuters
Thursday, January 10, 2013 - 11:25am
tags:
drug shortages, Flu, Tamiflu, Roche, Sanofi
Astex Pharmaceuticals: Heading For New Highs On Strong Pipeline Momentum
Seeking Alpha
Thursday, January 10, 2013 - 11:12am
tags:
Astex, Dacogen
Dynavax's Heplisav: Vaccinated Against Failure?
Seeking Alpha
Thursday, January 10, 2013 - 11:05am
tags:
Dynavax, Heplisav, vaccines, hepatitis B
Teva Petitions FDA To Delay Biogen MS Drug
Pharmalot
Thursday, January 10, 2013 - 9:53am
tags:
FDA, Teva, Biogen Idec, MS, multiple sclerosis, Copaxone, BG-12
J&J Diabetes Drug Faces Questions at FDA Advisory Panel
Motley Fool
Thursday, January 10, 2013 - 9:49am
tags:
diabetes, FDA, JNJ, advisory panel, canagliflozin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.